{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:03:55Z","timestamp":1761512635711},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.4065\/78.5.554","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:20:27Z","timestamp":1232760027000},"page":"554-560","source":"Crossref","is-referenced-by-count":16,"title":["Factors Influencing Clinical Decisions to Initiate Thyroxine Therapy for Patients With Mildly Increased Serum Thyrotropin (5.1-10.0 mIU\/L)"],"prefix":"10.4065","volume":"78","author":[{"given":"Vahab","family":"Fatourechi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Lankarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia G.","family":"Schryver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Vanness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten Hall","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George G.","family":"Klee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/78.5.554_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM200107263450406","article-title":"Clinical practice: subclinical hypothyroidism","volume":"345","author":"Cooper","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/78.5.554_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0025-6196(11)62389-6","article-title":"Subclinical thyroid disease","volume":"76","author":"Fatourechi","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/78.5.554_bib3","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1210\/jc.86.10.4585","article-title":"Subclinical hypothyroidism is mild thyroid failure and should be treated","volume":"86","author":"McDermott","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/78.5.554_bib4","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1210\/jc.86.10.4591","article-title":"The treatment of subclinical hypothyroidism is seldom necessary","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/78.5.554_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-129-2-199807150-00020","article-title":"Clinical guideline, part 2: screening for thyroid disease: an update [published correction appears in Ann Intern Med. 1999;130:246]","volume":"129","author":"Helfand","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.4065\/78.5.554_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.4065\/78.5.554_bib7","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.86.10.4860","article-title":"TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)","volume":"86","author":"Meier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/78.5.554_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-101-1-18","article-title":"L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial","volume":"101","author":"Cooper","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.4065\/78.5.554_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1988.tb00250.x","article-title":"A double-blind cross-over 12-month study of L-thyroxine treatment of women with \u2018subclinical\u2019 hypothyroidism","volume":"29","author":"Nystrom","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4065\/78.5.554_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF02598988","article-title":"Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?","volume":"11","author":"Jaeschke","year":"1996","journal-title":"J Gen Intern Med"},{"key":"10.4065\/78.5.554_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","article-title":"A 6-months randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"key":"10.4065\/78.5.554_bib12","first-page":"155","article-title":"The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community","volume":"6","author":"Vanderpump","year":"1996","journal-title":"Thyroid"},{"key":"10.4065\/78.5.554_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.4065\/78.5.554_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611619228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611619228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T08:27:11Z","timestamp":1545467231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611619228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["S0025619611619228"],"URL":"https:\/\/doi.org\/10.4065\/78.5.554","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}